Trial 3L-17-3


The role of quantitative contrast-enhanced ultrasound in YTTRIUM-90 (90Y) radioembolization of hepatocellular carcinoma

Type: Diagnostic
Phase: Not Applicable
Status: Not Open (Closed)
Treatments: Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Harshawn Malhi, M.D.
Other Trial Staff:  Steven Carrasco, Coordinator, Mario Franco, Coordinator, Rosaura Diaz, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.